DLD Asset Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

DLD Asset Management’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-40,000	Closed	-$3.01M	–	240
2022 Q2	$3.01M	Buy	+40,000	New	+$1.78M	0.21%	82

DLD Asset Management's TPTX Position: Q3 2022 in Review

DLD Asset Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 40,000 shares — an estimated $3.01M sold.

DLD Asset Management first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $3.01M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

DLD Asset Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
DLD Asset Management sold 40,000 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $3.01M.
DLD Asset Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
DLD Asset Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $3.01M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on DLD Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.